Dow Up 0.08% Nasdaq Down 0.30%

Aratana Therapeutics, Inc. (PETX)

-NasdaqGM
10.00 Down 0.03(0.30%) Sep 19, 4:00PM EDT
|After Hours : 10.00 0.00 (0.00%) Sep 19, 4:40PM EDT
Prev Close:10.03
Open:10.07
Bid:8.30 x 100
Ask:17.00 x 100
1y Target Est:27.60
Beta:5.808
Next Earnings Date: 6-Oct-14PETX Earnings announcement
Day's Range:9.73 - 10.29
52wk Range:9.60 - 29.32
Volume:435,771
Avg Vol (3m):227,591
Market Cap:287.83M
P/E (ttm):N/A
EPS (ttm):-0.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PETX

Comparison

Symbol% ChgMkt Cap
PETXDown 0.30%287.83M
ZTSUp 1.36%18.64B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):481.96
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.53
Quarterly EPS Est (Sep-14) :-0.42
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):-0.44

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aratana Therapeutics, Inc., a development-stage biopharmaceutical company, focuses on the licensing, acquisition, development, and commercialization of biopharmaceutical products for cats, dogs, and other companion animals worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback